Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Table 1. Characteristics of population. Characteristicsa Characteristicsa Characteristicsa ICS with autotransfusion N = 97 ICS with autotransfusion N = 97 ICS with autotransfusion N = 97 ICS without autotransfusion N = 196 ICS without autotransfusion N = 196 P P P Age, years Age, years Age, years 33.1 ± 5.0 33.1 ± 5.0 33.1 ± 5.0 32.5 ± 5.2 32.5 ± 5.2 0.37 0.37 0.37 BMIb, kg/m2 BMIb, kg/m2 BMIb, kg/m2 25.6 (22.3; 29.3) 25.6 (22.3; 29.3) 25.6 (22.3; 29.3) 25.4 (22.6; 29.6) 25.4 (22.6; 29.6) 0.75 0.75 0.75 Pregnancy parity Pregnancy parity Pregnancy parity 2 (1; 3) 2 (1; 3) 2 (1; 3) 2 (1; 4) 2 (1; 4) 0.22 0.22 0.22 Birth date Birth date Birth date 37 (35; 39) 37 (35; 39) 37 (35; 39) 38 (36; 39) 38 (36; 39) 0.06 0.06 0.06 Multiple pregnancy Multiple pregnancy Multiple pregnancy 10 (10.3) 10 (10.3) 10 (10.3) 18 (9.2) 18 (9.2) 0.76 0.76 0.76 History of PPHc History of PPHc History of PPHc 18 (18.6) 18 (18.6) 18 (18.6) 30 (15.31) 30 (15.31) 0.48 0.48 0.48 Obstetric indication for Cesarean Obstetric indication for Cesarean Obstetric indication for Cesarean Uterine scar Uterine scar Uterine scar 13 (13.4) 13 (13.4) 13 (13.4) 54 (27.6) 54 (27.6) 0.007 0.007 0.007 Placenta abnormality Placenta abnormality Placenta abnormality 57 (58.8) 57 (58.8) 57 (58.8) 90 (45.9) 90 (45.9) 0.04 0.04 0.04 Multiple pregnancy Multiple pregnancy Multiple pregnancy 7 (7.2) 7 (7.2) 7 (7.2) 15 (7.7) 15 (7.7) 0.90 0.90 0.90 Fetal Distress Fetal Distress Fetal Distress 6 (6.2) 6 (6.2) 6 (6.2) 18 (9.2) 18 (9.2) 0.38 0.38 0.38 Dystocia of labor Dystocia of labor Dystocia of labor 4 (4.1) 4 (4.1) 4 (4.1) 6 (3.1) 6 (3.1) 0.73 0.73 0.73 Maternal disease Maternal disease Maternal disease 8 (8.3) 8 (8.3) 8 (8.3) 15 (7.7) 15 (7.7) 0.86 0.86 0.86 Uterine abnormality Uterine abnormality Uterine abnormality 11 (11.3) 11 (11.3) 11 (11.3) 16 (8.2) 16 (8.2) 0.38 0.38 0.38 Pregnancy-related vascular disorder Pregnancy-related vascular disorder Pregnancy-related vascular disorder 5 (5.2) 5 (5.2) 5 (5.2) 14 (7.1) 14 (7.1) 0.52 0.52 0.52 Vaginal bleeding Vaginal bleeding Vaginal bleeding 4 (4.1) 4 (4.1) 4 (4.1) 6 (3.1) 6 (3.1) 0.73 0.73 0.73 Breech presentation Breech presentation Breech presentation 3 (3.1) 3 (3.1) 3 (3.1) 10 (5.1) 10 (5.1) 0.55 0.55 0.55 Type of Anesthesia Type of Anesthesia Type of Anesthesia General anesthesia General anesthesia General anesthesia 31 (32.0) 31 (32.0) 31 (32.0) 43 (21.9) 43 (21.9) 0.06 0.06 0.06 Epidural anesthesia Epidural anesthesia Epidural anesthesia 9 (9.3) 9 (9.3) 9 (9.3) 11 (5.6) 11 (5.6) 0.24 0.24 0.24 Spinal anesthesia Spinal anesthesia Spinal anesthesia 32 (33.0) 32 (33.0) 32 (33.0) 68 (34.7) 68 (34.7) 0.77 0.77 0.77 Combined spinal anesthesia Combined spinal anesthesia Combined spinal anesthesia 34 (35.1) 34 (35.1) 34 (35.1) 82 (41.8) 82 (41.8) 0.26 0.26 0.26 Urgency of Cesarean section Urgency of Cesarean section Urgency of Cesarean section Scheduled Scheduled Scheduled 65 (67.0) 65 (67.0) 65 (67.0) 138 (70.4) 138 (70.4) 0.55 0.55 0.55 Green code Green code Green code 15 (15.5) 15 (15.5) 15 (15.5) 26 (13.3) 26 (13.3) 0.61 0.61 0.61 Orange code Orange code Orange code 4 (4.1) 4 (4.1) 4 (4.1) 16 (8.2) 16 (8.2) 0.20 0.20 0.20 Red code Red code Red code 13 (13.4) 13 (13.4) 13 (13.4) 16 (8.2) 16 (8.2) 0.16 0.16 0.16 a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage a: Values are given in terms of average ± standard deviation, in terms of median (1st quartile; 3rd quartile) or in terms of frequency (percentage). b: BMI: Body mass index c: PPH: Post-partum Haemorrhage Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Table 2. Univariate analysis: autotransfusion according to the indications for Intraoperative cell salvage (ICS). Indication of ICS a ; b Indication of ICS a ; b Indication of ICS a ; b ICS with autotransfusion N=97 ICS with autotransfusion N=97 ICS with autotransfusion N=97 ICS without autotransfusion N =196 ICS without autotransfusion N =196 P P P Placenta abnormality Placenta abnormality Placenta abnormality 55 (56.7) 55 (56.7) 55 (56.7) 86 (43.9) 86 (43.9) 0.039 0.039 0.039 Placenta accreta Placenta accreta Placenta accreta 27 (27.8) 27 (27.8) 27 (27.8) 24 (12.2) 24 (12.2) < .001 < .001 < .001 Placenta previa Placenta previa Placenta previa 30 (30.9) 30 (30.9) 30 (30.9) 63 (32.1) 63 (32.1) 0.834 0.834 0.834 Risk factors for uterine atony Risk factors for uterine atony Risk factors for uterine atony 22 (22.7) 22 (22.7) 22 (22.7) 33 (16.8) 33 (16.8) 0.228 0.228 0.228 Uterine fibroids Uterine fibroids Uterine fibroids 13 (13.4) 13 (13.4) 13 (13.4) 10 (5.1) 10 (5.1) 0.013 0.013 0.013 Multiple pregnancy Multiple pregnancy Multiple pregnancy 10 (10.3) 10 (10.3) 10 (10.3) 18 (9.2) 18 (9.2) 0.758 0.758 0.758 Fetal macrosomia Fetal macrosomia Fetal macrosomia 1 (1.0) 1 (1.0) 1 (1.0) 5 (2.6) 5 (2.6) - - - Uterin scar Uterin scar Uterin scar 14 (14.4) 14 (14.4) 14 (14.4) 47 (24.0) 47 (24.0) 0.058 0.058 0.058 Postoperative bleeding Postoperative bleeding Postoperative bleeding 10 (10.3) 10 (10.3) 10 (10.3) 3 (1.5) 3 (1.5) 0.001 0.001 0.001 Maternal heart disease Maternal heart disease Maternal heart disease 3 (3.1) 3 (3.1) 3 (3.1) 5 (2.6) 5 (2.6) 0.723 0.723 0.723 Pregnancy-related vascular disorder Pregnancy-related vascular disorder Pregnancy-related vascular disorder 5 (5.2) 5 (5.2) 5 (5.2) 8 (4.1) 8 (4.1) 0.765 0.765 0.765 Preeclampsia Preeclampsia Preeclampsia 2 (2.1) 2 (2.1) 2 (2.1) 3 (1.5) 3 (1.5) - - - HELLP syndrome HELLP syndrome HELLP syndrome 1 (1.0) 1 (1.0) 1 (1.0) 2 (1.0) 2 (1.0) - - - Retroplacental hematoma Retroplacental hematoma Retroplacental hematoma 2 (2.1) 2 (2.1) 2 (2.1) 3 (1.5) 3 (1.5) - - - Transfusion difficulties Transfusion difficulties Transfusion difficulties 6 (6.2) 6 (6.2) 6 (6.2) 28 (14.3) 28 (14.3) 0.042 0.042 0.042 Rare blood group Rare blood group Rare blood group 0 (0) 0 (0) 0 (0) 24 (12.2) 24 (12.2) 0.001 0.001 0.001 Jehovah’s witness Jehovah’s witness Jehovah’s witness 1 (1.0) 1 (1.0) 1 (1.0) 1 (0.5) 1 (0.5) - - - Sickle cell disease Sickle cell disease Sickle cell disease 5 (5.2) 5 (5.2) 5 (5.2) 3 (1.5) 3 (1.5) 0.121 0.121 0.121 Haemostasis disorder Haemostasis disorder Haemostasis disorder 0 (0) 0 (0) 0 (0) 8 (4.1) 8 (4.1) 0.056 0.056 0.056 Prepartum anemia Prepartum anemia Prepartum anemia 3 (3.1) 3 (3.1) 3 (3.1) 4 (2.0) 4 (2.0) - - - History of severe PPH History of severe PPH History of severe PPH 5 (5.2) 5 (5.2) 5 (5.2) 15 (7.7) 15 (7.7) 0.425 0.425 0.425 Other indication Other indication Other indication 4 (4.1) 4 (4.1) 4 (4.1) 17 (8.7) 17 (8.7) 0.228 0.228 0.228 a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. a Values are given in terms of frequency (percentage). b Patients could have one, two or three indications for ICS. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Table 3. Multivariate analysis: autotransfusion according to the indications for Intraoperative cell salvage. Indication of ICS OR OR OR CI 95% CI 95% CI 95% P P Placenta accreta 3.42 3.42 3.42 [1.8 ; 6.54] [1.8 ; 6.54] [1.8 ; 6.54] < .001 < .001 Uterine fibroids 3.74 3.74 3.74 [1.49 ; 9.38] [1.49 ; 9.38] [1.49 ; 9.38] 0.005 0.005 Postoperative bleeding 10.15 10.15 10.15 [2.67 ; 38.53] [2.67 ; 38.53] [2.67 ; 38.53] < .001 < .001 Transfusion difficulties 0.11 0.11 0.11 [0.015 ; 0.85] [0.015 ; 0.85] [0.015 ; 0.85] 0.034 0.034 Uterine scar 0.80 0.80 0.80 [0.39 ; 1.63] [0.39 ; 1.63] [0.39 ; 1.63] 0.536 0.536 Other 0.70 0.70 0.70 [0.21 ; 2.18] [0.21 ; 2.18] [0.21 ; 2.18] 0.519 0.519